ArticleFrontiers in immunology2021

Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.

Helene Cabanas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.